{
  "docId": "019de075-3e55-76ad-a6bd-1aa5a42e575f",
  "docSlug": "085543019d5934281487d90fc26e88a2",
  "documentTitle": "argenx SE | Results Presentation Deck | 15 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 15,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "before_after",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "Kaplan-Meier survival curve showing probability of no relapse over 48 weeks.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/5",
  "deckHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f",
  "deckJsonHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json",
  "deckAnchorHref": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.55,
        "x": 0.43,
        "y": 0.2
      },
      "kind": "chart",
      "text": "Kaplan-Meier curve of probability of no relapse",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b406ea4-ab76-42a3-badc-6b04673a359c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.15,
        "y": 0.58
      },
      "kind": "metric",
      "text": "HR: 0.39 P = 0.000039",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e5a4827-866c-4674-9cb7-f94eaf4be60a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.15,
        "y": 0.28
      },
      "kind": "metric",
      "text": "67% - 78%",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e63c84d-6996-4dcd-ae3c-e5385a41f34d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.05,
        "y": 0.7
      },
      "kind": "paragraph",
      "text": "61% lower risk of relapse based on time to first adjusted INCAT deterioration with VYVGART Hytrulo compared to placebo",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74cc377d-26fa-4d91-a5e9-28e390997f2a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.05,
        "y": 0.37
      },
      "kind": "paragraph",
      "text": "Response rates demonstrate IgG autoantibodies play significant role in underlying CIDP biology",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a71bfe98-eb86-488e-9784-e761eb706f1a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "ADHERE: Opportunity to Transform CIDP Patient Experience",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34185c3e-0cf6-4487-a5aa-c6476c9bd8ad",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before-After-Bridge",
      "slug": "before-after-bridge",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "086d08c6-1d6d-4280-bb66-385b7f4f5bce",
      "evidence": "title/headline: ADHERE: Opportunity to Transform CIDP Patient Experience",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "05492dc3-bfd3-470d-936c-bceffef47c97",
      "arcName": "The Golden Circle",
      "arcSlug": "golden-circle",
      "beatName": "Problem",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "ADHERE: Opportunity to Transform CIDP Patient Experience",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 5,
      "name": "Before After",
      "slug": "21-before-after",
      "bestFor": "Product demos, process improvements, ROI justification",
      "matchId": "54f76381-9824-4185-9ad1-e421511382fa",
      "evidence": "The before-after comparison shows the opportunity to transform CIDP patient experience",
      "position": 1,
      "objective": "Highlight the benefits of ADHERE",
      "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
      "confidence": 0.7,
      "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}